Efficacy of a nicotine mouth spray in smoking cessation: a randomised, double-blind trial},

Tønnesen Philip, Lauri Hans, Perfekt Roland, Mann Karl, Batra Anil

Source: Eur Respir J 2012; 40: 548-554
Journal Issue: September
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Tønnesen Philip, Lauri Hans, Perfekt Roland, Mann Karl, Batra Anil. Efficacy of a nicotine mouth spray in smoking cessation: a randomised, double-blind trial},. Eur Respir J 2012; 40: 548-554

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Efficacy and safety of a novel nicotine mouth spray in smoking cessation: A randomized, placebo-controlled, double blind, multicenter study with 52-week follow up
Source: Annual Congress 2011 - Smoking cessation science
Year: 2011

Effect of pre-treatment with the nicotine patch on withdrawal symptoms in smokers subsequently quitting with the nicotine patch: a double-blind randomised controlled trial
Source: Eur Respir J 2002; 20: Suppl. 38, 612s
Year: 2002

A multicenter, randomised, double-blind, placebo-controlled 6 month trial to evaluate efficacy and tolerability of bupropion hydrochloride sustained release (SR) tablets as treatment for nicotine dependency in healthcare workers and as an aid to smoking
Source: Eur Respir J 2002; 20: Suppl. 38, 611s
Year: 2002

Aural electrical stimulation for smoking cessation – a double-blind, placebo controlled study
Source: Eur Respir J 2005; 26: Suppl. 49, 388s
Year: 2005

Short-term low-dose vs standard-dose Varenicline therapy for smoking cessation: a randomized controlled trial.
Source: International Congress 2017 – Smoking cessation treatment and e-cigarettes
Year: 2017


Randomized clinical trials with nicotine inhaler for smoking cessation
Source: Eur Respir J 2003; 22: Suppl. 45, 166s
Year: 2003

A randomised, double-blind, placebo-controlled phase 3 study investigating the efficacy of nicotine substitution (NS) on nicotine withdrawal symptoms (NWS) in hospitalised smokers (HS)
Source: Annual Congress 2009 - Smoking cessation
Year: 2009


Quit smoking with Champix: Parallel, randomised clinical trial of efficacy for the first time in Iran
Source: Annual Congress 2012 - Tobacco cessation and tobacco cessation services
Year: 2012


A multicenter, randomized, double-blind, double-dummy, 2-way crossover, single dose study, comparing the efficacy and safety of the fluticasone/salmeterol (500/50 μg) combination administered with the new Elpenhaler inhalation device versus the innovative one in patients with asthma
Source: Annual Congress 2009 - Quality of treatment in primary respiratory care
Year: 2009

Impact of oral clonidine on duration of opioid and benzodiazepine use in mechanically ventilated children: a randomized, double-blind, placebo-controlled study
Source: Virtual Congress 2020 – Neonatal and paediatric intensive care: diagnosis, management and outcomes
Year: 2020

Effect of reflexology, homeopathy, and traditional medical treatment in asthma: A randomised, controlled, parallel-group trial
Source: Annual Congress 2010 - Questionnaires use and psychological aspects in asthma
Year: 2010


Effectiveness of a multi-component intensive smoking cessation programme for COPD outpatients: A randomized controlled trial
Source: Annual Congress 2003 - COPD and smoking (cessation)
Year: 2003


Predictors of long-term smoking cessation in patients with COPD: results from a randomised controlled trial
Source: Eur Respir J, 49 (6) 1700561; 10.1183/13993003.00561-2017
Year: 2017



Short-term effect of a single dose of inhaled procaterol on exercise performance in COPD: a randomized, double blind, placebo-controlled, crossover trial
Source: Annual Congress 2008 - Physiological response to exercise performance
Year: 2008


Cost-effectiveness of self-management in asthmatics: a 1-yr follow-up randomized, controlled trial
Source: Eur Respir J 2001; 17: 206-213
Year: 2001



Late Breaking Abstract: Randomized, placebo-controlled trial of varenicline for smoking cessation with flexible quit dates
Source: Annual Congress 2010 - Smoking related disorders and smoking cessation
Year: 2010

Evaluation of ICS/LABA combination therapy on respiratory function in patients with asthma: Open-label, randomized, cross-over trial.
Source: International Congress 2018 – New developments in the treatment of asthma
Year: 2018


Regular extended release morphine for chronic breathlessness: a multi-centre double-blind RCT
Source: International Congress 2018 – Best abstracts in pulmonary rehabilitation and chronic care
Year: 2018




A placebo-controlled trial with varenicline for long term nicotine replacement product users
Source: Annual Congress 2011 - Smoking cessation science
Year: 2011